News in Review COVID-19: The Race for a Vaccine

News in Review COVID-19: The Race for a Vaccine

COVID-19 was first detected in December 2019 and quickly spread across the globe, infecting more than 75 million people and killing over 1.6 million by the end of the first year. As the disease resurged with a second wave, scientists and medical professionals around the world were in a tight race to develop an effective vaccine. In November 2020, pharmaceutical companies Pfizer, Moderna and Oxford-AstraZeneca all announced their vaccines showed good results in trial stages. Both Pfizer and Moderna developed gene-based vaccines and both firms declared 95 per cent efficacy. Within weeks, Pfizer's vaccine was being shipped around the world. Canada gave its first vaccine injection on December 14, 2020.

  • 2020
  • 00:15:17
  • 13-14
  • Added on: 02/01/2021
Curio.ca users can access content from outside their institution. You must find your access code and then create an account.

Metadata

Edition
January 2021
Subjects
Clinical trials [LCSH] COVID-19 (Disease) -- Prevention [LCSH] COVID-19 (Disease) -- Vaccination [LCSH] Vaccines -- Development [LCSH] Science [LCSH] Medical sciences [LCSH] Health education [LCSH] Health services administration [LCSH]
Team
Michael Serapio (Host), Vik Adhopia (Journalist), Christine Birak (Journalist), Renée Filippone (Journalist), Ashley Burke (Journalist), Alison Northcott (Journalist)
Closed captioning
Available
MARC Record
View Download

Teacher Guide(s)

  • NIR-21-01 - PPT - COVID-19: The Race for a Vaccine

    NIR-21-01 - PPT - COVID-19: The Race for a Vaccine

  • NIR-21-01 - PDF - COVID-19: The Race for a Vaccine

    NIR-21-01 - PDF - COVID-19: The Race for a Vaccine

Can be found in

The new version of Curio is available!

Access this page through the new version and discover a whole new experience.

Try the new version